Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: updated results from a retrospective matched-pair analysis

Gampenrieder, SP, Romeder, F, Muss, C, Pircher, M, Ressler, S, Rinnerthaler, G, Bartsch, R, Sattlberger, C, Mlineritsch, B, Greil, R

http://www.ncbi.nlm.nih.gov/pubmed/24403467